
This episode discusses the impact of the medications OIC, Wovi, and Mongero on American spending habits, particularly on food. The conversation highlights how these drugs could lead to significant savings for companies like United, with estimates of $80 million annually. Additionally, the episode touches on the potential health implications, such as reduced alcohol consumption and lower rates of knee replacements.
The hosts emphasize the scale of obesity in America, noting that 40% of the population is affected. They suggest that these medications represent a major breakthrough in healthcare, comparable to past technological advancements like GPS and the iPhone.
OIC, Wovi, and Mongero may transform American spending and health.

This episode stands out for the following:
This is probably the biggest technological breakthrough since GPS.Scott Galloway explains why he thinks weight loss drugs are the “biggest business story of 2023.”
62% less alcohol consumption? I'm overwhelmed.Scott Galloway explains why he thinks weight loss drugs are the “biggest business story of 2023.”